OKLO is trading 5% down today at $49.20 as investors take profits following the announcement of a major regulatory milestone for its Groves isotope test reactor.
- The company confirmed its reactor cleared the U.S. Department of Energy’s final major safety approval and is moving toward final startup steps, including fuel loading and criticality in July.
- The decline follows a significant rally leading up to the announcement, suggesting the milestone was already priced in by the market.
- Shares are also facing headwinds from a broader market pullback, with the Nasdaq Composite trading down 0.78% this morning.